Kyverna Therapeutics Inc.

NASDAQ: KYTX · Real-Time Price · USD
3.53
-0.01 (-0.28%)
At close: Aug 15, 2025, 3:59 PM
3.58
1.42%
After-hours: Aug 15, 2025, 06:09 PM EDT

Kyverna Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-127.48M -60.37M -28.89M -26.35M
Depreciation & Amortization
2.13M 1.71M 1.05M 586K
Stock-Based Compensation
8.36M 2.22M 929K 7.25M
Other Working Capital
7.12M -659K -7.03M -4.5M
Other Non-Cash Items
-5.12M 605K 1.41M 850K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
7.86M 3.42M -10.33M -4.49M
Operating Cash Flow
-114.25M -52.41M -36.11M -22.16M
Capital Expenditures
-2.21M -621K -768K -1.29M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-490M -54.85M -56.49M n/a
Sales Maturities Of Investments
323.64M 46.68M 43.17M n/a
Other Investing Acitivies
7.66M n/a -13.33M n/a
Investing Cash Flow
-160.9M -8.79M -14.1M -1.29M
Debt Repayment
-956K -781K -249K -41K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-3.1M -1M 175K 30K
Financial Cash Flow
337.11M 58.12M 11.88M 72.52M
Net Cash Flow
61.96M -3.08M -38.33M 49.08M
Free Cash Flow
-116.45M -53.03M -36.88M -23.44M